Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 The effect of human recombinant IGF-1 and temocapril on animal survival. Kaplan-Meier survival curves for the IGF-1-treated group (n = 8; open circles), the temocapril-treated group (n = 10; filled circles), and the control group (n = 10; open inverted triangles). The IGF-1, temocapril, or placebo was administrated from 11 weeks of age. *p < 0.01 or #p < 0.05 vs. control (log-rank test).
|
